Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis ofStaphylococcus aureus

  • 11 Accesses

  • 11 Citations

Abstract

We studied release of leukotriene B4 (LTB4) by human polymorphonuclear leukocytes (PMNs) during phagocytosis of staphylococci in the presence or absence of arachidonic acid. The 12×107 PMNs incubated with 3×109 opsonizedS. aureus and 50μM arachidonic acid released 1.45±0.42 nmol LTB4. No LTB4 was detected after stimulation of PMNs withS. aureus or arachidonic acid by themselves. However, by increasing the concentration of arachidonic acid to 200 or 400μM, 1.22±0.45 and 1.98±0.49 nmol LTB4, respectively, was released by PMNs. The effect of different bacteria-PMN ratios on LTB4 production was also studied. LTB4 varied from 0.3 to 2.0 nmol when bacteria/PMN ratios increased from 5 to 50 (respectively) in the presence of 50 μM arachidonic acid. Thus, phagocytizing PMNs produce LTB4 in the presence of arachidonic acid, and its production is dependent on the number of bacteria phagocytized.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Higgs, G. A., S. Bunting, S. Moncada, andJ. R. Vane. 1976. Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.Prostaglandins 12:749–757.

  2. 2.

    Zurier, R. B., andD. M. Sayadoff. 1975. Release of prostaglandins from human polymorphonuclear leukocytes.Inflammation 1:93–101.

  3. 3.

    Adkinson, N. F., Jr., T. Barron, S. Powell, andS. Cohen. 1977. Prostaglandin production by human peripheral blood cells in vitro.J. Lab. Clin. Med. 90:1043–1053.

  4. 4.

    Borgeat, P., andB. Samuelsson. 1979. Arachidonic acid metabolism in polymorphonuclear leukocytes: Effects of ionophore A23187.Proc. Natl. Acad. Sci. U.S.A. 76:2148–2152.

  5. 5.

    Goetzl, E. J., and F. F.Sun. Generation of unique monohydroxyeicosatetraenoic acid by human neutrophils.J. Exp. Med. 150:406–411.

  6. 6.

    Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley, andM. J. H. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.Nature 286:264–265.

  7. 7.

    Smith, M. J. H. 1982. Biological activities of leukotriene B4 (isomer III).In Leukotrienes and Other Lipoxygenase Products. B. Samuelsson, and R. Paoletti, editors, Raven Press, New York. 283–292.

  8. 8.

    Goldman, D. W., andE. J. Goetzl. 1982. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.J. Immunol. 129:1600–1604.

  9. 9.

    Kreisle, R. A., andC. W. Parker. 1983. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.J. Exp. Med. 157:628–641.

  10. 10.

    Dahlén, S.-E., J. Björk, P. Hedqvist, K.-E. Arfors, S. Hammerström, J.-A. Lindgren, andB. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response.Proc. Natl. Acad. Sci. U.S.A. 78:3887–3891.

  11. 11.

    Smith, M. J. H., A. W. Ford-Hutchinson, andM. A. Bray. 1980. Leukotriene B: A potential mediator of inflammation.J. Pharm. Pharmacol. 32:517–518.

  12. 12.

    Goetzl, E. J., andW. C. Pickett. 1980. The human PMN leukocyte chemotactic activity of complex hydroxyeicosatetraenoic acids (HETEs).J. Immunol. 125:1789–1791.

  13. 13.

    Palmer, R. M. J., andD. A. Yeats 1981. Leukotriene B: A potent chemotactic agent and stimulus for lysosomal enzyme secretion for human neutrophils (PMN).Br. J. Pharmacol. 73:260P-261P.

  14. 14.

    Bokoch, G. M., andP. W. Reed. 1981. Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes.J. Biol. Chem. 256:5317–5320.

  15. 15.

    Nagy, L., T. H. Lee, E. J. Goetzl, W. C. Pickett, andA. B. Kay. 1982. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.Clin. Exp. Immunol. 47:541–547.

  16. 16.

    Palmer, R. M. J., andJ. A. Salmon. 1983. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan, and the ionophore A23187.Immunology 50:65–73.

  17. 17.

    Claesson, H.-E., U. Lundberg, andC. Malmsten. 1981. Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP.Biochem. Biophys. Res. Commun. 99:1230–1237.

  18. 18.

    Nijkamp, F. P., S. Moncada, H. L. White, andJ. R. Vane 1977. Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets,Eur. J. Pharmacol. 44:179–186.

  19. 19.

    Verbrugh, H. A., R. Peters, P. K. Peterson, andJ. Verhoef. 1978. Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.J. Clin. Pathol. 31:539–545.

  20. 20.

    Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.Scand. J. Clin. Lab. Invest. 21(Suppl. 97: 77–89.

  21. 21.

    Verhagen, J., P. Walstra, G. A. Veldink, J. F. G. Vliegenthart, andP. L. B. Bruynzeel. 1984. Separation and quantitation of leukotrienes by reversed-phase high-performance liquid chromatography.Prostagl. Leukotr. Med. 13:15–20.

  22. 22.

    Verhagen J., P. L. B. Bruynzeel, J. A. Koedam, G. A. Wassink, M. De Boer, G. K. Terpstra, J. Kreukniet, G. A. Veldink, andJ. F. G. Vliegenthart. 1984. Specific leukotriene formation by purified human eosinophils and neutrophils.FEBS Lett. 168:23–28.

  23. 23.

    O'Flaherty, J. T., H. J. Showell, E. L. Becker, andP. A. Ward. 1979. Neutrophil aggregation and degranulation. Effect of arachidonic acid.Am. J. Pathol. 95:433–444.

  24. 24.

    Badwey, J. A., J. T. Curnutte, andM. L. Karnovsky. 1981. cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils.J. Biol. Chem. 256:12640–12643.

  25. 25.

    Yoshimoto, S., T. Yoshimoto, andE. Tsubara. 1982. Arachidonic acid-induced chemiluminescence of human polymorphonuclear leukocytes.Biochem. Biophys. Res. Commun. 107:779–784.

  26. 26.

    Henricks, P. A. J., M. E. van der Tol, J. H. van Kats-Renaud, F. P. Nijkamp, andJ. Verhoef. 1984. Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte function.Biochim. Biophys. Acta 801:206–214.

  27. 27.

    Henderson, W. R., andS. J. Klebanoff. 1983. Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils.J. Biol. Chem. 258:13522–13527.

  28. 28.

    Clancy, R. M., C. A. Dahinden, andT. E. Hugli. 1983. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.Proc. Natl. Acad. Sci. U.S.A. 80:7200–7204.

  29. 29.

    Waite, M., L. R. DeChatelet, L. King, andP. S. Shirley. 1979. Phagocytosis-induced release of arachidonic acid from human neutrophils.Biochem. Biophys. Res. Commun. 90:984–992.

  30. 30.

    Walsh, C. E., B. M. Waite, M. J. Thomas, andL. R. DeChatelet. 1981. Release and metabolism of arachidonic acid in human neutrophils.J. Biol. Chem. 256:7228–7234.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Henricks, P.A.J., Van Der Tol, M.E., Engels, F. et al. Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis ofStaphylococcus aureus . Inflammation 10, 37–47 (1986). https://doi.org/10.1007/BF00916039

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Arachidonic Acid
  • Polymorphonuclear Leukocyte
  • LTB4